News
-
-
COMMUNIQUÉ DE PRESSE
Onco-Innovations Advances Polymer Testing as It Moves Its PNKP Inhibitor Technology Toward IND-Enabling Studies
Onco-Innovations Limited announces advancement in analytical method for PNKP Inhibitor Technology, strengthening formulation development and scale-up for clinical manufacturing -
-
-
COMMUNIQUÉ DE PRESSE
Onco-Innovations Announces Completion of Analytical Method Development for Monomer Intermediate 1 Supporting ONC010 Program
Onco-Innovations successfully completes milestone with Dalton Pharma Services, developing analytical method for purity determination of Intermediate 1 supporting ONC010, enhancing drug delivery system quality control -
-
-
COMMUNIQUÉ DE PRESSE
Onco-Innovations Strengthens Executive Leadership with Appointment of Dr. Islam Mohamed as Chief Medical Officer and Stephen M. Novak as Chief of Research and Development
Onco-Innovations appoints Dr. Islam Mohamed as CMO and Stephen M. Novak as Chief of R&D, aiming to enhance clinical and development capabilities for advancing ONC010. Strategic leadership additions for Onco's transition to clinical-stage execution -
-
